• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价性护理指南的遵守与良性前列腺增生症手术的提供有关。

Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery.

机构信息

Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Urology. 2012 Jul;80(1):84-9. doi: 10.1016/j.urology.2012.03.011. Epub 2012 May 18.

DOI:10.1016/j.urology.2012.03.011
PMID:22608799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3392961/
Abstract

OBJECTIVE

To determine the impact of evaluative care guideline compliance on surgical intervention for benign prostatic hyperplasia (BPH).

METHODS

From Medicare claims data, we developed a cohort of men new to a urologist with a diagnosis of BPH. We determined urologists' compliance with guideline recommended care (3 months) and their time- and geography-standardized average monthly Medicare expenditures (1 year). At the level of the urologist, we assessed the impact of these measures on the use of surgical therapy within 1 year of the new patient visit.

RESULTS

Of 10 248 patients in the cohort, 675 received surgical intervention (6.7%). Guideline compliance (2% received surgery in highest quintile; 11% lowest quintile) was associated with surgical intervention. The results were robust to adjustment for patient and surgeon factors (Guideline Compliance, odds ratio = 0.09; 95% confidence interval = 0.06-0.15, highest to lowest adherence).

CONCLUSION

Urologists who tend to follow the AUA best practice guidelines for BPH evaluation perform surgical interventions on their BPH patients less frequently than urologists who do not follow these guidelines.

摘要

目的

确定评估性护理指南遵从性对良性前列腺增生(BPH)手术干预的影响。

方法

我们从医疗保险索赔数据中开发了一组新到泌尿科医生就诊的患有 BPH 的男性队列。我们确定了泌尿科医生对指南推荐护理的遵从性(3 个月)以及他们的时间和地理标准化的平均每月医疗保险支出(1 年)。在泌尿科医生层面,我们评估了这些措施对新患者就诊后 1 年内手术治疗使用的影响。

结果

在队列中的 10248 名患者中,有 675 名接受了手术干预(6.7%)。指南遵从性(2%的患者接受手术治疗,最高五分位数;11%的患者接受手术治疗,最低五分位数)与手术干预相关。结果在调整了患者和外科医生因素后仍然稳健(指南遵从性,比值比=0.09;95%置信区间=0.06-0.15,最高至最低依从性)。

结论

倾向于遵循 AUA 对 BPH 评估的最佳实践指南的泌尿科医生对其 BPH 患者进行手术干预的频率低于不遵循这些指南的泌尿科医生。

相似文献

1
Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery.评价性护理指南的遵守与良性前列腺增生症手术的提供有关。
Urology. 2012 Jul;80(1):84-9. doi: 10.1016/j.urology.2012.03.011. Epub 2012 May 18.
2
Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.泌尿科医生在 Medicare 人群中对良性前列腺增生症的 AUA 最佳实践指南的遵从情况。
Urology. 2011 Jul;78(1):3-9. doi: 10.1016/j.urology.2010.12.087. Epub 2011 May 23.
3
Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.泌尿科医生在评估老年男性良性前列腺增生症时的实践模式。
Urology. 2011 Mar;77(3):535-40. doi: 10.1016/j.urology.2010.07.485. Epub 2011 Jan 21.
4
[Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].[CTMH指南对良性前列腺增生管理的影响评估]
Prog Urol. 2015 Jan;25(1):47-53. doi: 10.1016/j.purol.2014.09.049.
5
Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation.医疗保险人群中良性前列腺增生评估初始支出的变化:与整体医疗保险通货膨胀的比较。
J Urol. 2012 May;187(5):1739-46. doi: 10.1016/j.juro.2011.12.079. Epub 2012 Mar 15.
6
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.《良性前列腺增生所致下尿路症状的外科治疗:2019 年 AUA 指南修订版》
J Urol. 2019 Sep;202(3):592-598. doi: 10.1097/JU.0000000000000319. Epub 2019 Aug 8.
7
Differences in initial benign prostatic hyperplasia management between primary care physicians and urologists.基层医疗医生和泌尿科医生在初始良性前列腺增生管理方面的差异。
J Urol. 2009 Nov;182(5):2410-4. doi: 10.1016/j.juro.2009.07.029. Epub 2009 Sep 17.
8
Contemporary practice patterns of endoscopic surgical management for benign prostatic hyperplasia among urologists in the United States.美国泌尿科医生治疗良性前列腺增生的内镜手术管理的当代实践模式。
J Urol. 2013 May;189(5):1811-6. doi: 10.1016/j.juro.2012.11.171. Epub 2012 Dec 3.
9
CROATIAN UROLOGISTS' CLINICAL PRACTICE AND COMPLIANCE WITH GUIDELINES IN THE MANAGEMENT OF NON-NEUROGENIC MALE LOWER URINARY TRACT SYMPTOMS.克罗地亚泌尿外科医生在非神经源性男性下尿路症状管理中的临床实践与指南遵循情况
Acta Clin Croat. 2015 Dec;54(4):453-7.
10
A Multifaceted Assessment of Benign Prostatic Hyperplasia Practice and AUA Guideline Adherence.良性前列腺增生症实践的多方面评估和 AUA 指南的遵守情况。
Urol Pract. 2024 Nov;11(6):950-955. doi: 10.1097/UPJ.0000000000000654. Epub 2024 Jul 2.

引用本文的文献

1
High regional variation in prostate surgery for benign prostatic hyperplasia in Switzerland.瑞士良性前列腺增生症前列腺手术的地区差异很大。
PLoS One. 2021 Jul 22;16(7):e0254143. doi: 10.1371/journal.pone.0254143. eCollection 2021.
2
Network Meta-Analysis of the Efficacy of Acupuncture, Alpha-blockers and Antibiotics on Chronic Prostatitis/Chronic Pelvic Pain Syndrome.针刺、α受体阻滞剂及抗生素治疗慢性前列腺炎/慢性盆腔疼痛综合征疗效的网状Meta分析
Sci Rep. 2016 Oct 19;6:35737. doi: 10.1038/srep35737.
3
Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.药物治疗的应用以及激光手术和经尿道前列腺切除术治疗良性前列腺增生的效果
Urology. 2015 Dec;86(6):1115-22. doi: 10.1016/j.urology.2015.07.019. Epub 2015 Sep 12.
4
Latest developments in the assessment and treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: what is clinically relevant?提示良性前列腺增生的下尿路症状评估与治疗的最新进展:哪些具有临床相关性?
Clin Drug Investig. 2015 Feb;35 Suppl 1:3-6. doi: 10.1007/s40261-014-0258-2.

本文引用的文献

1
Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.泌尿科医生在 Medicare 人群中对良性前列腺增生症的 AUA 最佳实践指南的遵从情况。
Urology. 2011 Jul;78(1):3-9. doi: 10.1016/j.urology.2010.12.087. Epub 2011 May 23.
2
Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.泌尿科医生在评估老年男性良性前列腺增生症时的实践模式。
Urology. 2011 Mar;77(3):535-40. doi: 10.1016/j.urology.2010.07.485. Epub 2011 Jan 21.
3
The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment.笔与手术刀:信息传播对外科治疗非临床差异的影响
Med Care. 2009 Jul;47(7):749-57. doi: 10.1097/MLR.0b013e31819748b3.
4
How much do patients' preferences contribute to resource use?患者的偏好对资源利用有多大影响?
Health Aff (Millwood). 2009 May-Jun;28(3):864-73. doi: 10.1377/hlthaff.28.3.864.
5
Discretionary decision making by primary care physicians and the cost of U.S. Health care.初级保健医生的自由裁量决策与美国医疗保健成本
Health Aff (Millwood). 2008 May-Jun;27(3):813-23. doi: 10.1377/hlthaff.27.3.813.
6
Extending the P4P agenda, part 1: how Medicare can improve patient decision making and reduce unnecessary care.拓展按绩效付费议程,第1部分:医疗保险如何改善患者决策并减少不必要的医疗服务。
Health Aff (Millwood). 2007 Nov-Dec;26(6):1564-74. doi: 10.1377/hlthaff.26.6.1564.
7
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.一种用于乳腺癌、前列腺癌、结直肠癌和肺癌患者基于索赔研究的精细化共病测量算法。
Ann Epidemiol. 2007 Aug;17(8):584-90. doi: 10.1016/j.annepidem.2007.03.011. Epub 2007 May 25.
8
Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.抗精神病药物剂量指南的依从性与健康状况、副作用及患者护理体验之间的关联。
Med Care. 2006 Sep;44(9):827-34. doi: 10.1097/01.mlr.0000215806.11805.6c.
9
Unequal use of new technologies by race: the use of new prostate surgeries (transurethral needle ablation, transurethral microwave therapy and laser) among elderly Medicare beneficiaries.不同种族对新技术的使用差异:老年医疗保险受益人群中新型前列腺手术(经尿道针刺消融术、经尿道微波热疗和激光手术)的使用情况
J Urol. 2006 May;175(5):1830-5; discussion 1835. doi: 10.1016/S0022-5347(05)00997-3.
10
Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia.良性前列腺增生症药物及手术治疗的地域差异。
J Urol. 2006 Mar;175(3 Pt 1):1023-7. doi: 10.1016/S0022-5347(05)00409-X.